Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An intermediate fibroblastic neoplasm arising from the lung. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells.
Biomarker and diagnostic research for lung inflammatory myofibroblastic tumor has been reported in the published literature.
No clinical trials have been registered for lung inflammatory myofibroblastic tumor.
98 publications have been identified in PubMed for lung inflammatory myofibroblastic tumor. Research spans Case Report / Case Series (58%), Basic Science / Preclinical (19%), and Review / Meta-Analysis (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 57 | 58% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:05 PM UTC
Laboratory research
19 |
19% |
Research summaries | 10 | 10% |
Testing and diagnosis research | 4 | 4% |
New treatment approaches | 4 | 4% |
Disease patterns and progression | 3 | 3% |
Other research | 1 | 1% |
Hirano Y (2026). [PMID: 41577803](https://pubmed.ncbi.nlm.nih.gov/41577803/). *NPJ Precis Oncol*. [Basic Science / Preclinical]
Youssef YT (2026). [PMID: 41694434](https://pubmed.ncbi.nlm.nih.gov/41694434/). *J Surg Case Rep*. [Case Report / Case Series]
Gu X (2026). [PMID: 41883986](https://pubmed.ncbi.nlm.nih.gov/41883986/). *Cyborg Bionic Syst*. [Basic Science / Preclinical]
Jaiswal A (2026). [PMID: 41576947](https://pubmed.ncbi.nlm.nih.gov/41576947/). *Cell Genom*. [Basic Science / Preclinical]
Ermakov MS (2026). [PMID: 42092301](https://pubmed.ncbi.nlm.nih.gov/42092301/). *J Pathol*. [Basic Science / Preclinical]
He W (2026). [PMID: 41841092](https://pubmed.ncbi.nlm.nih.gov/41841092/). *Cureus*. [Case Report / Case Series]
Ding J (2026). [PMID: 41271031](https://pubmed.ncbi.nlm.nih.gov/41271031/). *Toxicol Appl Pharmacol*. [Basic Science / Preclinical]
Elgohary R (2026). [PMID: 40637744](https://pubmed.ncbi.nlm.nih.gov/40637744/). *Naunyn Schmiedebergs Arch Pharmacol*. [Basic Science / Preclinical]
Collins JM (2026). [PMID: 41037490](https://pubmed.ncbi.nlm.nih.gov/41037490/). *J Infect Dis*. [Review / Meta-Analysis]
Jacob S (2026). [PMID: 42067665](https://pubmed.ncbi.nlm.nih.gov/42067665/). *Virchows Arch*. [Basic Science / Preclinical]